Sales Force Effectiveness USA 2012

Face it, this year you will have to 'do more with less'.         SFE US 2012 will show you how...

...Pharma is in flux.

That's an understatement. Customers have evolved, pipelines have shrunk, thousands of stakeholders need attention and budgets are restricted. The sales and marketing rule book is being completely rewritten. But it's not all bad...

The speed of customer change is driving unprecedented innovation

Right now, we're questioning 'norms', revisiting 'proven' tactics, looking for new approaches. "It's not about shiny new iPads, but changing the way we look at our customers and taking advantage of all of the opportunities available to us.." - Andreas Claus Kistner, Global Head of Commercial Architecture, Roche.

The themes you identified

We spent several months talking to people exactly like you. This has thrown up clear themes upon which the latest event is founded:

• The technology we can now bring into play has never been so accessible or powerful. We'll explore how to harness tablets, smartphones and the latest applications to deliver big returns.
• We used to deal with Physicians... now we're facing everybody from Payers to Patient Groups What really works when you're shooting to build profitable relationships with such diverse 'stakeholders'? You'll find the answers here, because we're bringing the new players - FDC, Aetna, Blue Cross Blue Shield, United Healthcare and Patients to the event.
• Big money customers are harder to work with than ever before. SFE strategies of old won't wash in the era of value. We'll be hearing how KAM thinking is morphing at Pfizer, GSK and other leading innovators as they look to keep key relationships on track
• New markets are vital to growth as the developed pharma world gets more complicate. Sure, the opportunities in territories like Brazil, China, India, Turkey and Mexico are huge. But the dynamics are tough and very variable. How do we best carve out market share without getting burned?

Last year's event was brilliant - here's what some of our delegates had to say:

Recent years in our industry have taught us that it's better to anticipate and adapt than to be forced to react. Forums such as SFE 2011 provide insights into new options and ideas that build our capabilities as sales leaders of tomorrow

Barry Duke, Vice President Sales, Genzyme

The conference was very enjoyable. I gained valuable information from high-level speakers, and also enjoyed the networking component as well. Thank you for your hard work, and I look forward to the next SFE Conference!

Michael R. Williamson, Sr. Manager, SFE , MedImmune

View a Presentation From Last Year:

Streamline your CRM approach to enhance your sales

Jonathan Sweig, Associate Director Commercial Operations, International IT, Genzyme Corporation

Thinking of attending in 2012? Want to see who you could be rubbing shoulders with? Click here to see a sample of who attended SFE USA 2011

I look forward to meeting you in New Jersey & please don’t hesitate to contact me.

Theo Fellgett VP Europe | eyeforpharma Tel: +44 (0) 207 375 7591 theo@eyeforpharma.com LinkedIn: Theo Fellgett